Seroxat Antidepressant Glaxo Smith Kline

Featured Article

Paxil maker GlaxoSmithKline has agreed to pay several states $14 million to settle allegations that it blocked generic forms of Paxil, causing patients in those states to pay higher prices. GlaxoSmithKline was charged with filing frivolous patent-infringement lawsuits to allow it to extend Paxil's patent and thus keep generic versions of the drug off the market.

Read more

More information on "Seroxat Antidepressant Glaxo Smith Kline"

From Our Experts

See more SharePosts »

From Our Sources

More on Depression »